Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial.
Article in Journal of the American Heart Association (April 2024)
The most recent citing publications are shown below. View all 26 publications that cite this research output on Dimensions.
Article in Journal of the American Heart Association (April 2024)
Article in European Journal of Vascular and Endovascular Surgery (November 2023)
Article in Theranostics (June 2022)